The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: Time for a reappraisal

Journal of Heart and Lung Transplantation

Volumn 16, Issue 7, 1997, Pages 743-751

  Mehra, M R ^a   Ventura, H O ^a   Chambers, R B ^a   Ramireddy, K ^a   Smart, F W ^a   Stapleton, D D ^a  

^a OCHSNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; HYDROCORTISONE; METHYLPREDNISOLONE; OKT 3; PREDNISONE; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; FEMALE; GRAFT REJECTION; HEART PRESERVATION; HEART TRANSPLANTATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT FAILURE; VASCULAR DISEASE;

ADULT; AGED; CORONARY DISEASE; CORONARY VESSELS; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030838967     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)